Ancillary Symposia-Improving Outcomes in Acromegaly: Let Your Patients Be Your Guide
Ancillary Symposia-Improving Outcomes in Acromegaly: Let Your Patients Be Your Guide
Monday, June 8, 2020
Program: 12:00- 1:30 pm EDT
This course is a virtual live CME-certified Ancillary Symposium to be presented at ENDO Online 2020. This educational activity is supported by an independent medical educational grant from Chiasma, Inc. This ancillary symposium is developed through the Endocrine Society’s Special Programs Committee (SPC).
PLEASE REGISTER THEN CLICK "START" TO:
DOWNLOAD PRESENTATION SLIDES
PRINT A CERTIFICATE OF ATTENDANCE OR CERTIFICATE OF PARTICIPATION
This activity is intended for endocrinologists and endocrine fellows, primary care physicians, physician’s assistants, nurse practitioners and other healthcare professionals.
Upon completion of this educational activity, learners will be able to:
- Assess the pathophysiology and clinical symptomology associated with acromegaly to improve patient recognition and diagnosis
- Examine common comorbidities associated with acromegaly and the burden on patient quality of life despite endocrine control
- Review the latest clinical evidence regarding emerging treatments for the management of patients with acromegaly
- Evaluate the importance of communicating with patients regarding their disease state and realistic treatment expectations
Through didactic presentations and challenging case scenarios, this program will provide an opportunity to address the pathophysiology and clinical symptomology, examine common comorbidities, review treatment options associated with acromegaly and encourage health care professionals to change their practice behaviors to improve their patients’ health. This symposium is certified for 1.5 AMA PRA Category 1 Credits™ and 1.5 ABIM MOC points.
Massachusetts General Hospital
STATEMENT OF INDEPENDENCE
As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's Special Programs Committee (SPC). The commercial supporter(s) of this activity have no influence over the planning of this CME activity.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
- Adriana G. Ioachimescu, MD, PhD: Research Investigator Novartis Pharmaceuticals, Chiama, Inc., Strongbridge
- Lisa B. Nachtigall, MD: Advisory Board Member Spouse, Pfizer, Inc., Corcept; Consultant, Pfizer, Inc.; Grant, Ipsen; Research Investigator, Chiasma
- Shlomo Melmed, MD: Advisory Board Member, Chiasma, Inc; Consultant, Ionis, Midatech, Crinetics, Rami, Ipsen; Research Grant, Pfizer, Inc.
- Andjela T. Drincic, MD: Advisory Board Member, Corcept
- Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Esperion, AstraZeneca
- Angela M. Leung, MD: Speaker,Medical Education Resources, MCE Conferences
- Amy Rothberg, MD: Advisor, Rhythm Pharmaceuticals; Spouse, consultant of Merck
The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.
- Katherine Araque, MD; Beret Ann Casey, MD; Jenny Blau, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Deborah Sellmeyer, MD, Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD
The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.
Use of professional judgment:
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.
Drugs and dosages:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.
POLICY ON UNLABELED/OFF-LABEL USE
The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.
PRIVACY AND CONFIDENTIALITY STATEMENT
The Endocrine Society will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.
This educational activity is supported by an independent medical educational grant from Chiasma, Inc.
Click "Start" to complete the meeting evaluation, claim CME, and print a certificate of attendance or certificate of participation.
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.
The Endocrine Society designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™ and 1.5 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions about content or obtaining CME credit, please contact the Endocrine Society at education.endocrine.org/contact.
MAINTENANCE OF CERTIFICATION
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
REVIEW YOUR DIPLOMATE ABIM ID NUMBER(S)
In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:
- Provide your board-certification information in your educational profile. Your profile currently contains the following board ID numbers (must be logged in to view):
Your ABIM Number: *
*If your ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.
- 1.50 ABIM MOC
- 1.50 AMA PRA Category 1 Credits™
- 1.50 CME Certificate of Participation